1. Home
  2. NTRA vs WBD Comparison

NTRA vs WBD Comparison

Compare NTRA & WBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • WBD
  • Stock Information
  • Founded
  • NTRA 2003
  • WBD 1923
  • Country
  • NTRA United States
  • WBD United States
  • Employees
  • NTRA N/A
  • WBD N/A
  • Industry
  • NTRA Medical Specialities
  • WBD Cable & Other Pay Television Services
  • Sector
  • NTRA Health Care
  • WBD Telecommunications
  • Exchange
  • NTRA Nasdaq
  • WBD Nasdaq
  • Market Cap
  • NTRA 20.9B
  • WBD 22.7B
  • IPO Year
  • NTRA 2015
  • WBD N/A
  • Fundamental
  • Price
  • NTRA $158.25
  • WBD $9.82
  • Analyst Decision
  • NTRA Strong Buy
  • WBD Buy
  • Analyst Count
  • NTRA 17
  • WBD 23
  • Target Price
  • NTRA $183.00
  • WBD $12.01
  • AVG Volume (30 Days)
  • NTRA 1.5M
  • WBD 39.7M
  • Earning Date
  • NTRA 05-08-2025
  • WBD 05-08-2025
  • Dividend Yield
  • NTRA N/A
  • WBD N/A
  • EPS Growth
  • NTRA N/A
  • WBD N/A
  • EPS
  • NTRA N/A
  • WBD N/A
  • Revenue
  • NTRA $1,831,000,000.00
  • WBD $38,342,000,000.00
  • Revenue This Year
  • NTRA $18.39
  • WBD N/A
  • Revenue Next Year
  • NTRA $16.72
  • WBD $0.89
  • P/E Ratio
  • NTRA N/A
  • WBD N/A
  • Revenue Growth
  • NTRA 51.50
  • WBD N/A
  • 52 Week Low
  • NTRA $92.14
  • WBD $6.64
  • 52 Week High
  • NTRA $183.00
  • WBD $12.70
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 53.16
  • WBD 62.96
  • Support Level
  • NTRA $153.93
  • WBD $9.66
  • Resistance Level
  • NTRA $165.91
  • WBD $10.19
  • Average True Range (ATR)
  • NTRA 4.59
  • WBD 0.31
  • MACD
  • NTRA 0.23
  • WBD 0.12
  • Stochastic Oscillator
  • NTRA 48.03
  • WBD 77.37

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About WBD Warner Bros. Discovery Inc. Series A

Warner Bros. Discovery was formed in 2022 through the combination of WarnerMedia and Discovery Communications. It operates in three global business segments: studios, networks, and direct-to-consumer. Warner Bros. Pictures is the crown jewel of the studios business, producing, distributing, and licensing movies and television shows. The networks business consists of basic cable networks, such as CNN, TNT, TBS, Discovery, HGTV, and the Food Network. Direct-to-consumer includes HBO and the firm's streaming platforms, which have now been consolidated to Max and Discovery+. Much of the DTC content is created within the firm's other two business segments. Each segment operates with a global reach, with Max available in over 70 countries.

Share on Social Networks: